Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;155(9):1080-1082.
doi: 10.1001/jamadermatol.2019.1668.

Distinct Histopathologic Patterns of Finger Eruptions in Dermatomyositis Based on Myositis-Specific Autoantibody Profiles

Affiliations

Distinct Histopathologic Patterns of Finger Eruptions in Dermatomyositis Based on Myositis-Specific Autoantibody Profiles

Naoko Okiyama et al. JAMA Dermatol. .

Abstract

This histologic analysis of cutaneous manifestations of dermatomyositis examines whether skin eruptions can be histopathologically classified into myositis-specific autoantibodies-associated groups.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fujimoto reported grants from Japanese Government during the conduct of the study; grants and personal fees from Maruho, Kyowa Kirin Pharma, Torii Pharma, the Japan Blood Product Organization, Tanabe Mitsubishi Pharma, Taiho Pharma, Ono Pharma, and Novartis, personal fees from Sanofi, Jansen Pharma, and personal fees from Celgene outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Histologic Analyses
The percentages of patients grouped into anti–aminoacyl-transfer RNA synthetase (ARS, dark blue bars), antimelanoma differentiation-associated protein 5 (MDA5, blue bars), and antitranscriptional intermediary factor 1γ (TIF1γ, light blue bars) antibodies-associated dermatomyositis groups showing interface dermatitis, psoriasiform dermatitis, eczematous reaction, and vascular injury in the upper dermis, respectively. Interface dermatitis was determined using a total score of 2 or greater, which was evaluated with liquefaction degeneration of the basal layer and dyskeratotic cells (0, absent; 1, <5 cells per field [ × 100]; and 2, ≥5 cells per field, respectively). Psoriasiform dermatitis was determined by a total score of 2 or greater, which was evaluated with psoriasiform acanthosis (0, absent; 1, present) and parakeratosis (0, absent; 1, <50% of field; and 2, ≥50% of field). Eczematous reaction was determined by the presence or absence of spongiosis (absent, <50% of field; and present, ≥50% of field), and vascular injury was assessed by inflammatory cell infiltration into vessel walls and bleeding. B, The remainders (score for dyskeratotic cells minus the score for liquefaction degeneration of the basal layer) for each group were calculated. The squares and bars represent medians and interquartile ranges (IQRs), respectively. C, The MxA expression index in each group was evaluated by calculating the percentage of MxA-expressing epidermal areas (0, 0%; 1, 1%-24%; 2, 25%-49%; 3, 50%-74%; 4, 75%-99%; 5, 100%). The boxes containing lines and bars represent the IQRs with medians and full ranges, respectively. The dots indicate individual MxA values.

References

    1. Concha JSS, Merola JF, Fiorentino D, Werth VP. Re-examining mechanic’s hands as a characteristic skin finding in dermatomyositis. J Am Acad Dermatol. 2018;78(4):769-775.e2, e762. - PubMed
    1. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65(1):25-34. doi: 10.1016/j.jaad.2010.09.016 - DOI - PMC - PubMed
    1. Uruha A, Suzuki S, Nishino I. Author update: sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology. 2017;89(2):215. doi: 10.1212/WNL.0000000000004102 - DOI - PubMed
    1. Uruha A, Nishikawa A, Tsuburaya RS, et al. Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology. 2017;88(5):493-500. doi: 10.1212/WNL.0000000000003568 - DOI - PubMed
    1. Zhang SH, Zhao Y, Xie QB, Jiang Y, Wu YK, Yan B. Aberrant activation of type I interferon system may contribute to the pathogenesis of anti-MDA5 dermatomyositis. Br J Dermatol. 2018;180(5):1090-1098. - PubMed